Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies

Clin Exp Immunol. 2015 May;180(2):178-88. doi: 10.1111/cei.12483.

Abstract

Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis is B cell-dependent, although how particular B cell subsets modulate immunopathogenesis remains unknown. Although their phenotype remains controversial, regulatory B cells (Bregs ), play a role in immunological tolerance via interleukin (IL)-10. Putative CD19(+) CD24(hi) CD38(hi) and CD19(+) CD24(hi) CD27(+) Bregs were evaluated in addition to their CD5(+) subsets in 69 patients with ANCA-associated vasculitis (AAV). B cell IL-10 was verified by flow cytometry following culture with CD40 ligand and cytosine-phosphate-guanosine (CpG) DNA. Patients with active disease had decreased levels of CD5(+) CD24(hi) CD38(hi) B cells and IL-10(+) B cells compared to patients in remission and healthy controls (HCs). As IL-10(+) and CD5(+) CD24(hi) CD38(hi) B cells normalized in remission within an individual, ANCA titres decreased. The CD5(+) subset of CD24(hi) CD38(hi) B cells decreases in active disease and rebounds during remission similarly to IL-10-producing B cells. Moreover, CD5(+) B cells are enriched in the ability to produce IL-10 compared to CD5(neg) B cells. Together these results suggest that CD5 may identify functional IL-10-producing Bregs . The malfunction of Bregs during active disease due to reduced IL-10 expression may thus permit ANCA production.

Keywords: AAV; ANCA; CD5; interleukin-10; regulatory B cells.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • ADP-ribosyl Cyclase 1 / blood
  • ADP-ribosyl Cyclase 1 / immunology
  • Adjuvants, Immunologic / pharmacology
  • Adult
  • Aged
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / blood
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / pathology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / therapy
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • B-Lymphocytes, Regulatory / immunology*
  • B-Lymphocytes, Regulatory / metabolism
  • B-Lymphocytes, Regulatory / pathology
  • CD24 Antigen / blood
  • CD24 Antigen / immunology
  • CD40 Antigens / blood
  • CD40 Antigens / immunology
  • CD5 Antigens / blood
  • CD5 Antigens / immunology
  • Female
  • Flow Cytometry
  • Gene Expression Regulation / immunology*
  • Humans
  • Interleukin-10 / blood
  • Interleukin-10 / immunology*
  • Male
  • Membrane Glycoproteins / blood
  • Membrane Glycoproteins / immunology
  • Middle Aged
  • Oligodeoxyribonucleotides / pharmacology
  • Remission Induction

Substances

  • Adjuvants, Immunologic
  • Antibodies, Antineutrophil Cytoplasmic
  • CD24 Antigen
  • CD24 protein, human
  • CD40 Antigens
  • CD5 Antigens
  • CPG-oligonucleotide
  • IL10 protein, human
  • Membrane Glycoproteins
  • Oligodeoxyribonucleotides
  • Interleukin-10
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1